159 related articles for article (PubMed ID: 26583157)
1. High Avidity dsDNA Autoantibodies in Brazilian Women with Systemic Lupus Erythematosus: Correlation with Active Disease and Renal Dysfunction.
Oliveira RC; Oliveira IS; Santiago MB; Sousa Atta ML; Atta AM
J Immunol Res; 2015; 2015():814748. PubMed ID: 26583157
[TBL] [Abstract][Full Text] [Related]
2. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
Su Y; Jia RL; Han L; Li ZG
Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
[TBL] [Abstract][Full Text] [Related]
3. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: a comparison with anti-dsDNA and anti-C1q.
Mok CC; Birmingham DJ; Ho LY; Hebert LA; Song H; Rovin BH
Lupus; 2012 Jan; 21(1):36-42. PubMed ID: 21993384
[TBL] [Abstract][Full Text] [Related]
5. Correlations between antinucleosome antibodies and anti-double-stranded DNA antibodies, C3, C4, and clinical activity in lupus patients.
Saisoong S; Eiam-Ong S; Hanvivatvong O
Clin Exp Rheumatol; 2006; 24(1):51-8. PubMed ID: 16539819
[TBL] [Abstract][Full Text] [Related]
6. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
Mok CC; Ho LY; Leung HW; Wong LG
Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
[TBL] [Abstract][Full Text] [Related]
7. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis.
Bizzaro N; Villalta D; Giavarina D; Tozzoli R
Autoimmun Rev; 2012 Dec; 12(2):97-106. PubMed ID: 22810055
[TBL] [Abstract][Full Text] [Related]
8. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.
Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P
Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675
[TBL] [Abstract][Full Text] [Related]
9. Serum DNase I activity in systemic lupus erythematosus: correlation with immunoserological markers, the disease activity and organ involvement.
Skiljevic D; Jeremic I; Nikolic M; Andrejevic S; Sefik-Bukilica M; Stojimirovic B; Bonaci-Nikolic B
Clin Chem Lab Med; 2013 May; 51(5):1083-91. PubMed ID: 23183758
[TBL] [Abstract][Full Text] [Related]
10. Immunoserological parameters in SLE: high-avidity anti-dsDNA detected by ELISA are the most closely associated with the disease activity.
Andrejevic S; Jeremic I; Sefik-Bukilica M; Nikolic M; Stojimirovic B; Bonaci-Nikolic B
Clin Rheumatol; 2013 Nov; 32(11):1619-26. PubMed ID: 23857662
[TBL] [Abstract][Full Text] [Related]
11. Assessment of a high-avidity IgG ANAs for the diagnosis and activity prediction of systemic lupus erythematosus.
Zeng Y; Lin Y; Wang X; Zhang Y; Peng F; Wang J; Jiang L; Liang S; Xiao Y
Clin Rheumatol; 2020 Sep; 39(9):2619-2629. PubMed ID: 32189150
[TBL] [Abstract][Full Text] [Related]
12. CD69 to CD3 ratio of peripheral blood mononuclear cells as a marker to monitor systemic lupus erythematosus disease activity.
Su CC; Shau WY; Wang CR; Chuang CY; Chen CY
Lupus; 1997; 6(5):449-54. PubMed ID: 9229364
[TBL] [Abstract][Full Text] [Related]
13. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
14. Analysis of immunity index and immunopathogenesis pattern of lupus nephritis patients.
Gao JX; Diao HL; Liu YQ; Lv M; Dong H; Zhang XM; Wang YN
J Biol Regul Homeost Agents; 2015; 29(1):201-6. PubMed ID: 25864759
[TBL] [Abstract][Full Text] [Related]
15. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
Lim KL; Jones AC; Brown NS; Powell RJ
Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
[TBL] [Abstract][Full Text] [Related]
16. Association of Serum Ferritin Levels with Hematological Manifestations in Systemic Lupus Erythematosus Patients from Western India.
Pradhan V; Pandit P; Rajadhyaksha A; Patwardhan M; Surve P; Kamble P; Lecerf M; Bayry J; Kaveri S; Ghosh K; Nadkar MY
J Assoc Physicians India; 2016 May; 64(5):14-18. PubMed ID: 27735143
[TBL] [Abstract][Full Text] [Related]
17. Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study.
Manson JJ; Ma A; Rogers P; Mason LJ; Berden JH; van der Vlag J; D'Cruz DP; Isenberg DA; Rahman A
Arthritis Res Ther; 2009 Oct; 11(5):R154. PubMed ID: 19828047
[TBL] [Abstract][Full Text] [Related]
18. Study on the correlation between anti-ribosomal P protein antibody and systemic lupus erythematosus.
Wang Y; Luo P; Guo T; Zou L; Shi J; Chen P
Medicine (Baltimore); 2020 May; 99(20):e20192. PubMed ID: 32443340
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of total and high-avidity anti-dsDNA antibody assays for the diagnosis of systemic lupus erythematosus.
Yuan W; Cao H; Wan P; Shi R; Zhou S; Zheng J
Lupus; 2019 Oct; 28(12):1387-1396. PubMed ID: 31570052
[TBL] [Abstract][Full Text] [Related]
20. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
